Showing results (31-40 of 283) with videos related to
Sort By:
Pageof 29
Medical and Pediatric Oncology|January 1, 1977
Lymphocyte function in the blood of patients with untreated non-Hodgkin lymphoma: influence of stage and pathologyN Thatcher, N Gasiunas, D CrowtherAnaesthesia|May 4, 2019
A study of temperature control in different designs of emergency drug transport bagsJ Dingley, N Thatcher, D WilliamsCancer|September 15, 1980
Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrextate, and vitamin AN Thatcher, G Blackledge, D CrowtherJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanomaB W Hancock, K Wheatley, S Harris, et al.Chest|May 1, 1996
Aggressive vs nonaggressive therapy for metastatic NSCLCN Thatcher, R M Niven, H AndersonCurrent Oncology Reports|December 21, 2000
Management of elderly patients with lung cancerM R Ranson, S White, N ThatcherExpert Review of Anticancer Therapy|July 13, 2002
Temozolomide: a novel oral alkylating agentS J Danson, M R MiddletonBritish Journal of Haematology|October 1, 1981
The migratory properties of indium-111 oxine labelled lymphocytes in patients with chronic lymphocytic leukaemiaJ Wagstaff, C Gibson, N Thatcher, et al.Histopathology|December 14, 2006
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reportsJ King, N Thatcher, C Pickering, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusionD Smith, J Wagstaff, N Thatcher, et al.Pageof 29